Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Article
  • Published:

Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer

Abstract

The insertion of suicide genes in donor T lymphocytes constitutes the basis of new approaches aiming at the treatment of the graft-versus-host disease (GVHD), a frequent complication in recipients of allogeneic haematopoietic grafts. In this study we investigated the impact that the ex vivo manipulation required for the retroviral transduction of T cells had on the functionality and differentiation of these cells. Compared to fresh T cells, samples that had been subjected to standard activation (1 μg/ml of both anti-CD3i and anti-CD28i MoAbs) followed by transduction with vectors encoding for the HSV-tk and tNGFR genes maintained the proliferative response to an allogeneic stimulus. These cells, however, had a significantly lower cytotoxic response to allogeneic cells compared to fresh samples. When the concentration of anti-CD3i was reduced to up to 1000-fold (1 ng/ml), similar T-cell transductions were obtained, while the cytotoxicity of the ex vivo manipulated samples was significantly recovered, when assessed either at 7 or 14 days of culture. In all instances, a similar functionality was observed in transduced samples not subjected to immunomagnetic cell sorting, compared to purified fractions enriched in NGFR+ and NFGR cells. The analysis of CD45RA and CCR7 markers in samples transduced under standard stimulatory conditions showed a differentiation of fresh CD8+ CD45RA+/CCR7+ naive cells to cells having a predominant central CD45RA/CCR7+ and effector CD45RA/CCR7 memory phenotype. However, when samples were activated with low doses of anti-CD3i, a significant population of naive cells became apparent. Although activation with high doses of anti-CD3i/anti-CD28i resulted in a similar phenotype in both NGFR+ and NFGR populations, the naive population observed in samples activated with low concentrations of anti-CD3i was almost restricted to the NGFR population. These results show that reducing the stimulation mediated by anti-CD3i in protocols of T-cell retroviral gene transfer significantly helps to preserve the cytotoxic capacity of these cells to allogeneic cells, without affecting the susceptibility of these cells to the retroviral vector. In addition, we observed that modulating the activation of transduced T cells implies the generation of changes in the differentiation of CD8+ cells, although we could not establish a direct relationship between the CD45RA/CCR7 phenotype of these cells and their cytotoxic reactivity to an allogeneic stimulus.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Ferrara JL, Deeg HJ . Graft-versus-host disease. N Engl J Med 1991; 324: 667–674.

    Article  CAS  PubMed  Google Scholar 

  2. Kolb HJ, Holler E . Adoptive immunotherapy with donor lymphocyte transfusions. Curr Opin Oncol 1997; 9: 139–145.

    Article  CAS  PubMed  Google Scholar 

  3. Martin PJ et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 1988; 3: 445–456.

    CAS  PubMed  Google Scholar 

  4. Marmont AM et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120–2130.

    CAS  PubMed  Google Scholar 

  5. Broers AE et al. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation. Blood 2000; 95: 2240–2245.

    CAS  PubMed  Google Scholar 

  6. Dazzi F, Goldman JM . Adoptive immunotherapy following allogeneic bone marrow transplantation. Annu Rev Med 1998; 49: 329–340.

    Article  CAS  PubMed  Google Scholar 

  7. Bordignon C et al. Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation. Hum Gene Ther 1995; 6: 813–819.

    Article  CAS  PubMed  Google Scholar 

  8. Bonini C et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia [see comments]. Science 1997; 276: 1719–1724.

    Article  CAS  PubMed  Google Scholar 

  9. Cohen JL et al. Prevention of graft-versus-host disease in mice using a suicide gene expressed in T lymphocytes. Blood 1997; 89: 4636–4645.

    CAS  PubMed  Google Scholar 

  10. Cohen JL, Boyer O, Klatzmann D . Suicide gene therapy of graft-versus-host disease: immune reconstitution with transplanted mature T cells. Blood 2001; 98: 2071–2076.

    Article  CAS  PubMed  Google Scholar 

  11. Tiberghien P et al. Use of donor T-lymphocytes expressing herpes-simplex thymidine kinase in allogeneic bone marrow transplantation: a phase I–II study. Hum Gene Ther 1997; 8: 615–624.

    Article  CAS  PubMed  Google Scholar 

  12. Tiberghien P et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 2001; 97: 63–72.

    Article  CAS  PubMed  Google Scholar 

  13. Lamana ML, Segovia JC, Guenechea G, Bueren JA . Systematic analysis of clinically applicable conditions leading to a high efficiency of transduction and transgene expression in human T cells. J Gene Med 2001; 3: 32–41.

    Article  CAS  PubMed  Google Scholar 

  14. Quinn ER, Lum LG, Trevor KT . T cell activation modulates retrovirus-mediated gene expression [see comments]. Hum Gene Ther 1998; 9: 1457–1467.

    Article  CAS  PubMed  Google Scholar 

  15. Pollok KE et al. Costimulation of transduced T lymphocytes via T cell receptor–CD3 complex and CD28 leads to increased transcription of integrated retrovirus. Hum Gene Ther 1999; 10: 2221–2236.

    Article  CAS  PubMed  Google Scholar 

  16. Ferrand C et al. Retrovirus-mediated gene transfer in primary T lymphocytes: influence of the transduction/selection process and of ex vivo expansion on the T cell receptor beta chain hypervariable region repertoire. Hum Gene Ther 2000; 11: 1151–1164.

    Article  CAS  PubMed  Google Scholar 

  17. Di Ianni M et al. T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection. Cancer Gene Ther 2000; 7: 920–926.

    Article  CAS  PubMed  Google Scholar 

  18. Duarte RF et al. Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. Gene Therapy 2002; 9: 1359–1368.

    Article  CAS  PubMed  Google Scholar 

  19. Sauce D et al. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein–Barr virus potential through both culture-dependent and selection process-dependent mechanisms. Blood 2002; 99: 1165–1173.

    Article  CAS  PubMed  Google Scholar 

  20. Berger C, et al., CD28 costimulation and immunoaffinity-based selection efficiently generate primary gene-modified T cells for adoptive immunotherapy. Blood 2002; 22: 22.

    Google Scholar 

  21. van Dijk AM et al. Determination of helper T-cell precursor frequencies against non-haemopoietic cells: comparison of co-stimulation provided by anti-CD28 antibody versus the cellular ligand B7-1. Br J Haematol 2000; 110: 322–326.

    Article  CAS  PubMed  Google Scholar 

  22. Dong H, Zhu G, Tamada K, Chen L . B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365–1369.

    Article  CAS  PubMed  Google Scholar 

  23. June CH, Ledbetter JA, Linsley PS, Thompson CB . Role of the CD28 receptor in T-cell activation. Immunol Today 1990; 11: 211–216.

    Article  CAS  PubMed  Google Scholar 

  24. Contassot E et al. In vivo alloreactive potential of ex vivo-expanded primary T lymphocytes. Transplantation 1998; 65: 1365–1370.

    Article  CAS  PubMed  Google Scholar 

  25. Drobyski WR, Majewski D, Ozker K, Hanson G . Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment. J Immunol 1998; 161: 2610–2619.

    CAS  PubMed  Google Scholar 

  26. Lenardo MJ . Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991; 353: 858–861.

    Article  CAS  PubMed  Google Scholar 

  27. Nagata S, Golstein P . The Fas death factor. Science 1995; 267: 1449–1456.

    Article  CAS  PubMed  Google Scholar 

  28. Weijtens M et al. Reduced graft-versus-host disease-inducing capacity of T cells after activation, culturing, and magnetic cell sorting selection in an allogeneic bone marrow transplantation model in rats. Hum Gene Ther 2002; 13: 187–198.

    Article  CAS  PubMed  Google Scholar 

  29. Marktel S et al. Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T cell-depleted stem cell transplantation. Blood 2003; 101: 1290–1298.

    Article  CAS  PubMed  Google Scholar 

  30. Deeths MJ, Kedl RM, Mescher MF . CD8+ T cells become nonresponsive (anergic) following activation in the presence of costimulation. J Immunol 1999; 163: 102–110.

    CAS  PubMed  Google Scholar 

  31. Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection [published erratum appears in Mol Cell Biol 1992 Jan; 12(1): 433]. Mol Cell Biol 1990; 10: 4239–4242.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Sallusto F et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708–712.

    Article  CAS  PubMed  Google Scholar 

  33. Champagne P et al. Skewed maturation of memory HIV-specific CD8T lymphocytes. Nature 2001; 410: 106–111.

    Article  CAS  PubMed  Google Scholar 

  34. Dardalhon V et al. Highly efficient gene transfer in naive human T cells with a murine leukemia virus-based vector. Blood 2000; 96: 885–893.

    CAS  PubMed  Google Scholar 

  35. Pollok KE et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol 1998; 72: 4882–4892.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Fehse B et al. Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin. Br J Haematol 1998; 102: 566–574.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Sergio García for excellent technical assistance in the generation and tittering of infective supernatants. Also the authors thank Paloma López for the preparation of peripheral blood samples. This work was supported by grants of the Comisión Interministerial de Ciencia y Tecnología (SAF 2002-030234) and Programa Redes de Investigación Cooperativa del Ministerio de Sandidad y Consumo (G03/073).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lamana, M., Bueren, J., Vicario, J. et al. Functional and phenotypic variations in human T cells subjected to retroviral-mediated gene transfer. Gene Ther 11, 474–482 (2004). https://doi.org/10.1038/sj.gt.3302188

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302188

Keywords

This article is cited by

Search

Quick links